SHANGHAI and HONG KONG, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" or "the company", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class...
from PR Newswire: https://ift.tt/2NTLWv3
No comments:
Post a Comment